Breast Cancer

  • Marla J. Tobin


Breast cancer, a fear of most women, is commonly seen by family physicians. It is the second most common female cancer killer, passed only by lung cancer in recent years. Except for skin cancer it is the most commonly seen cancer in women, with approximately 184,300 new cases of invasive breast cancer diagnosed in 1996 and 44,300 deaths. Breast cancer primarily affects women, but 2400 cases a year and 260 deaths annually (fewer than 1% of all breast cancers) occur in men.


Breast Cancer Family Physician High Risk Woman Nipple Discharge Breast Cyst 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bard R, Multimodality imaging of breast disease. Female Patient 1996;21:17–22.Google Scholar
  2. 2.
    Bell MC, Partridge EE. Early breast carcinoma: risk factors, screening, and treatment. Contemp Obstet Gynecol 1995; Dec:31–51.Google Scholar
  3. 3.
    Breast cancer special issue, J Am Med Worn Assoc 1992;47: 140–206.Google Scholar
  4. 4.
    Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589–93.PubMedCrossRefGoogle Scholar
  5. 5.
    Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer. JAMA 1994;272:947–54.PubMedCrossRefGoogle Scholar
  6. 6.
    GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. JAMA 1995;271:1587–97.Google Scholar
  7. 7.
    Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 1995;332:907–11.PubMedCrossRefGoogle Scholar
  8. 8.
    Kalllove H, Liberati A, Keeler E, Brook RH. Benefits and costs of screening and treatment for early breast cancer. JAMA 1995;273:142–54.CrossRefGoogle Scholar
  9. 9.
    Kopans DB, Marchant DJ, Osborne MP. Breast cancer vigilance, not panic. Patient Care 1993;Nov 15:135–64.Google Scholar
  10. 10.
    Love N. Breast cancer and primary care. Postgrad Med 1995; 98:43–110.Google Scholar
  11. 11.
    Olivotto IA. Adjuvant systemic therapy for women with breast cancer. Female Patient 1996;21:45–52.Google Scholar
  12. 12.
    Parker S, Wingo PA, Heath CW Jr. ACS breast cancer facts & figures. Atlanta, GA: American Cancer Society, 1996. Monograph 95–20M-NO.8610.Google Scholar
  13. 13.
    Phillips DM, Balducci L. Current management of breast cancer. Am Fam Physician 1996;53:657–65.PubMedGoogle Scholar
  14. 14.
    Rimer BK, Trock B, Balshem A, Engstrom PF, Rosan J, Lerman C. Breast screening practices among primary care physicians: reality and potential. J Am Board Fam Pract 1990;3: 26–34.PubMedGoogle Scholar
  15. 15.
    Rosenfeld JA. Evaluation of nonlactational nipple discharge. Female Patient 1995;20:39–49.Google Scholar
  16. 16.
    US Preventative Services Task Force. Guide to clinical preventative services. 2nd ed. Baltimore: Williams & Wilkins, 1996:73–87.Google Scholar
  17. 17.
    Utian WH, Wulf H, Ades TB, et al. Overcoming your patients’ fear of breast cancer. Menopause Manag 1994; Nov/Dec:18–28.Google Scholar
  18. 18.
    Webb MS. Reconstruction’s place in breast cancer management. Contemp Obstet Gynecol 1994;Aug:83–90.Google Scholar
  19. 19.
    Weitzel JN. Genetic counseling for familial cancer risk. Hosp Pract 1996;Feb 15:57–69.Google Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Marla J. Tobin

There are no affiliations available

Personalised recommendations